Login

CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Interview with Dr Daniel Matjila, CEO of Public Investment Corporation | Abel Sithole, CEO, Public Investment Corporation (SOC) Ltd.AS OF 31 AUG 2023
00:10:00
The Future of Uranium Mining and Nuclear Energy in Western Australia
00:10:00
Dario Melpignano, CEO of Neosperience, spoke at the Confindustria Young Entrepreneurs conference in Rapallo, addressing recent industry developments.
00:10:00
Top 5 Criteria for Choosing a Record Keeper
00:10:00
Comacchio Spa: Training the Next Generation of Specialized Construction Operators
00:10:00
Strategic Insights with Viktor Garmiani: Candles Scandinavia's Vision for Growth | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Arteris CEO sees big future in small FPGAs | K. Charles Janac, CEO, Arteris IncAIP:NMQ
00:10:00
Middle Market Lending Trends and Industry Focus
00:10:00
Geopolitics and De-globalization: Their Impact on Upstream and Downstream Battery Materials
00:10:00
MIT Club of GB Fireside Chat: Dave Butler on Leadership Lessons in Financial Services and the Intersection of Sports and Investing at Dimensional Fund Advisors (DFA)
00:10:00
Green Bonds Series: Investing in Social and Sustainability Bonds
00:10:00
Honoring Our Heroes: Insights from Veterans on Service and Transition | Jarrad Turner, Sr., Vice President of Strategic Partnerships at The Warrior Alliance

© 2026 Nehu